NYSE:OSCR News 24 November 2025

Oscar Health stock steadies premarket after ACA subsidies vote; UBS lifts rating

Oscar Health shares traded flat at $16.90 premarket Friday after a 2.6% rally Thursday, as investors watched House action on ACA subsidies and a UBS upgrade. UBS raised Oscar to neutral, citing steadier exchange enrollment. CTO Mario Schlosser sold 76,962 shares this week under a preset plan. The House-passed subsidy bill now moves to the Senate, with negotiations ongoing.

9 January 2026

NYSE:OSCR·Stock Market

Oscar Health Stock (OSCR) News Today: ACA Subsidy Cliff, Analyst Price Targets, and 2026 Open Enrollment Signals (Dec. 15, 2025)

Oscar Health shares traded near $16.63 on December 15, 2025, as the ACA open enrollment deadline coincided with new analyst coverage and policy debate in Washington. Congress is weighing the fate of enhanced ACA premium tax credits set to expire at the end of 2025. KFF projects average subsidized premiums could more than double in 2026 if subsidies lapse. Oscar’s business is heavily exposed to these ACA marketplace shifts.

15 December 2025

NYSE:OSCR·Stock Market

Oscar Health (OSCR) Stock Today: Fresh Analyst Coverage, Big 2027 Profit Hopes and Policy Risk in Focus

Oscar Health, Inc. (NYSE: OSCR) is back under the market’s spotlight on December 11, 2025, as Wall Street adds new coverage, doubles down on long‑term profit targets, and investors digest another bout of volatility in this high‑growth, high‑risk health‑insurtech name. While legacy giants such as American International Group, Inc. (AIG) dominate traditional insurance lines, Oscar is trying to reinvent health coverage for the Affordable Care Act (ACA) era with a tech‑first platform, AI tools, and aggressive geographic expansion. That experiment is playing out in real time in the stock price. Oscar Health stock today: volatile in the mid‑$15s As of

11 December 2025

NYSE:OSCR·Stock Market

Oscar Health (OSCR) Stock: Can a 35% Rally Survive Fresh Downgrades and ACA Uncertainty? – December 7, 2025

Oscar Health Inc. (NYSE: OSCR) has just delivered one of the wildest weeks in its short public-market life: the stock jumped roughly 35% on hopes that the White House will extend Affordable Care Act (ACA) subsidies, then ran straight into a wall of new downgrades and rising bearish options activity. Investopedia+2Reuters+2 As of the latest close, Oscar shares trade around $16.77, giving the health-tech insurer a market value of roughly $4.4–4.5 billion. That leaves the stock about 30% below its 52‑week high of $23.80 and roughly 50% above its 52‑week low of $11.20. StockAnalysis+1 Below is a deep dive into

7 December 2025

NYSE:OSCR·Stock Market

Oscar Health (OSCR) Stock Soars on Obamacare Subsidy Hopes as AI-Powered Virtual Care Rewrites Its Growth Story

Oscar Health Inc. (NYSE: OSCR) is back in the spotlight on Monday, November 24, 2025, as its stock surges on reports of a potential extension of Obamacare subsidies — just days after fresh analysis highlighted how AI-driven virtual care, new regional expansions, and a changing Wall Street stance are reshaping the company’s long-term story. Investing.com+2Simply Wall St+2 ACA Subsidy Extension Talk Sends Oscar Health Shares Higher Oscar Health shares jumped sharply in premarket trading on Monday after a report that the White House is preparing to propose a two-year extension of Affordable Care Act (ACA) subsidies, with new limits on

24 November 2025

Artificial Intelligence·NYSE:OSCR·Stock Market·Technology

Wall Street Feels the Heat (and Thrill): Fed Cuts, Tariffs & Mega-Mergers Set NYSE Buzz

Stock Market Today 08.02.2026

8 February 2026

LIVEMarkets rolling coverageStarted: February 8, 2026, 12:00 AM ESTUpdated: February 8, 2026, 12:54 AM EST Australian Shares Set for Volatile Earnings Season Amid Market Sensitivity February 8, 2026, 12:49 AM EST. **Australian stock markets** face heightened volatility as earnings season kicks off with little room for error. Analysts warn that even a **1% earnings miss** could trigger sharp price swings, stripping away previous insulation from market shocks. This turbulence reflects the removal of 'shock absorbers' in share prices, signaling an unpredictable three weeks ahead for investors. Anthony Macdonald, business journalist and Chanticleer columnist, forecasts significant fluctuations likely exceeding historical norms.

Tower Semiconductor stock jumps again on Nvidia optics tie-up as earnings near

8 February 2026

Tower Semiconductor shares rose 7.7% to $139.04 Friday after announcing a collaboration with Nvidia on AI data-center networking. The stock touched $141 intraday and gained another 1% after hours. Investors await Tower’s Feb. 11 earnings for details on its silicon photonics work. No financial terms or shipment timeline were disclosed.

Longsys Electronics stock heads into Monday after new guarantees; what 301308 investors watch next

8 February 2026

Longsys disclosed new guarantees for a 100 million yuan Hong Kong loan and a $9 million Brazil credit line, bringing its total approved guarantee quota to 11 billion yuan and outstanding guarantees to 5.81 billion yuan. The company said all guarantees are for consolidated subsidiaries and within approved limits. Shares closed at 288 yuan Friday, down 1.6%. China inflation and credit data are due this week.

MACOM stock price steadies near highs into Monday after earnings pop and fresh filings

8 February 2026

MACOM shares rose 3.5% to $235.87 Friday after the company reported fiscal Q1 revenue of $271.6 million and raised its full-year data center growth outlook to 35–40%. Fidelity’s FMR LLC disclosed a 10.7% stake, while shareholder Susan Ocampo filed to potentially sell up to 100,000 shares. Stifel raised its price target to $255. MACOM expects to repay $161 million in convertible notes in March.

NYSE:OSCR News 24 November 2025 - 9 January 2026

Stock Market Today